Views Differ On Australian Proposal To Link Review Of CDx With Drugs
Executive Summary
An Australian proposal to establish a regulatory framework for companion diagnostics has drawn a mixed response from pharmaceutical, biotech and medtech companies on issues like concurrent evaluation, product classification and unique identification.